ACI submits tox data to FSA
The Association for the Cannabinoid Industry (ACI) submitted a complete toxicological package to the Food Standards Agency (FSA) on Friday, 4 November 2022, to support members’ novel food applications. These applications account for 33% of the applications made to the FSA, and align to approximately half of the products identified on the public list. Currently […]
Experts in botanical ingredients turn their attention to cannabinoids
It’s not often you come across a company in the CBD world that has four decades of history. Susanne Caspar, Chief Executive of Linnea talks about succeeding in the botanical ingredients business and opening the doors to cannabinoids. Located in Switzerland, Linnea has been delivering botanical ingredients to the pharmaceutical, food and cosmetic industries across […]
Goodbody Health’s Polish arm, Sativa Wellness, on ‘ultra-pure’ CBD
Cannabinoid Insight ‘met’ Dr Krzysztof Wojtanowski in March by video link. With the head office based in the UK, Goodbody Health has acquired Sativa Wellness, in Bilcza, south-central Poland, where the main focus is on the production of ultra-pure CBD isolate and broad-spectrum THC-free distillate. Both are compliant with ISO 22000 Food Safety Management procedures. […]
List of CBD products: 100% of ACI consortium applications appear on the FSA’s list
The UK has become the first country in the world to regulate the market for safe, orally consumed legal cannabis extracts, following the release today of the Food Standards Agency’s public list of CBD products permitted for sale to consumers. Among the 70 applicants who have successfully made the list are 45 members of the […]
Landmark day for UK CBD industry as FSA publishes long awaited list of products permitted for sale
The Food Standards Agency has today published a list of the first CBD products allowed to remain on sale in the UK, with more than 3,500 products making the cut. For the first time, CBD oils, drinks, capsules, gummies and more edibles are permitted by the food safety body for sale, pending full market authorisation. […]
FSA update: Rebranding, new products and novel food applications. What does the future hold for white labelled CBD?
The Food Standards Agency (FSA) has doubled down on its novel foods guidance for white labelled CBD oils, edibles and beverages. They say no brands launched after 13 February 2020 are permitted to enter the UK market without full novel foods authorisation. The FSA, which is responsible for protecting public health in relation to food […]
FSA provides update on the status of the public list, white labelling and looming deadline
The Food Standards Agency (FSA) has said the public list of approved CBD products will be updated ‘as and when applications have been validated.’ The FSA will release a list in bulk form in the interim, indicating the applications which are ‘awaiting evidence’. A spokesperson for the food safety body met with the Association for […]
Planning to attend a CBD expo this year? 5 trade shows in the UK to add to your calendar
CBD expos are making a comeback in 2022 as the business world bounces back following two consecutive years of cancellations. One popular exhibition centre in London was even converted into an NHS Nightingale hospital, providing essential support to the healthcare system in the capital at the height of the health emergency. From choosing the right […]
Everything you need to know about CBD vapes
Updated 30.08.2022 Vaping has enjoyed a rise in popularity in the UK in recent years. There are now an estimated 4.3 million British adults who vape, with many taking up the habit as a means to quit smoking. New data from Action on Smoking and Health (ASH), suggests 8.3% of adults in England, Wales and Scotland vape […]
FSA issues clarification and new deadline for toxicology data
A number of CBD companies have until 28 February to provide sufficient toxicology data to the Food Standards Agency, or risk losing the right to sell their products. Cannabinoid Insight has learnt that up to 40 CBD companies which submitted summary data on epilepsy drug Epidiolex in their novel foods application, have until 28 February […]
